Sobi™ publishes the report for the first quarter 2018
Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces the results for the first quarter 2018. Total revenues grew 41 per cent compared to Q1 2017 and amounted to SEK 1,964 M. EBITA was SEK 771 M, an increase of 90 per cent and gross margin amounted to 72 per cent (74). 2018 off to a strong start · Total revenues of SEK 1,964 M (1,396) · 41 per cent sales growth in the quarter compared to Q1 2017(43 per cent at constant exchange rates, CER) · EBITA increased with 90 per cent to SEK 771 M (406) · Net cash position of SEK 1,744 M (1,472 as of 31